Dermatology Times 2024: The Year’s Biggest Breakthroughs, Innovations, and Clinical Insights
Explore the top dermatology news of 2024, highlighting breakthroughs, innovations, and key clinical insights shaping the future of skin care and treatment.
Related Articles
Welcoming 2025 With Innovation, Insights, and Impact
We’re welcoming 2025 with dermatology innovations, expert insights on chronic hand eczema, and new leadership at Dermatology Times.
Achieving Both Itch Improvement and Skin Clearance is Crucial, According to AD Patient Expectations
Real-world data from TARGET-DERM AD revealed that those with both reduced itch and clearer skin had the lowest levels of disease burden.
2025 AAD Annual Meeting
The 2025 AAD Annual Meeting is scheduled to take place March 7-11 in Orlando, Florida. Delve into an atmosphere of cutting-edge education led by dermatology…
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
Multi-Institutional Asylum Medicine Educational Initiative for Dermatology Residents
This survey study investigates the results of a multi-institutional clinical forensic dermatology training for residents.
Study Finds SME Enhances Skin Hydration and Reduces Wrinkles
Unlike bakuchiol, which exhibited toxicity at higher concentrations, SME demonstrated no cytotoxic effects in vitro.
Peristomal Erosion in a Man With Crohn Disease
A man in his 50s with a 10-year history of Crohn disease had intermittent bowel obstructions leading to total proctocolectomy and ileostomy, and 5 weeks…
The Dermatology Industry Landscape: Unpacking Economic and Mergers & Acquisitions Movements
The dermatology market remains an exciting space with strong demand for its valuable services, bolstered by positive US economic trends and robust consumer spending.
Sarcopenia and Osteoporosis: Overlapping Risks in Patients With Psoriatic Arthritis
A study uncovers the prevalence of sarcopenia and osteoporosis in patients with PsA, emphasizing the interconnected role of body composition and bone health.